HLS Therapeutics Inc. (FRA:74D)
Germany flag Germany · Delayed Price · Currency is EUR
2.860
+0.020 (0.70%)
At close: Dec 1, 2025

HLS Therapeutics Revenue

HLS Therapeutics had revenue of $13.51M USD in the quarter ending September 30, 2025, a decrease of -4.08%. This brings the company's revenue in the last twelve months to $55.85M, down -1.92% year-over-year. In the year 2024, HLS Therapeutics had annual revenue of $56.62M, down -10.23%.

Revenue (ttm)
$55.85M
Revenue Growth
-1.92%
P/S Ratio
1.98
Revenue / Employee
$607.03K
Employees
92
Market Cap
94.48M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202456.62M-6.46M-10.23%
Dec 31, 202363.07M1.61M2.61%
Dec 31, 202261.47M1.46M2.43%
Dec 31, 202160.01M3.90M6.95%
Dec 31, 202056.11M1.95M3.60%
Dec 31, 201954.16M-7.26M-11.81%
Dec 31, 201861.42M-13.67M-18.20%
Dec 31, 201775.08M21.05M38.96%
Dec 31, 201654.03M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition